Screener
CytomX Therapeutics CTMX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's net margin?
- CytomX Therapeutics (CTMX) reported net margin of -435.2% in Q2 2026.
- How has CytomX Therapeutics's net margin changed year-over-year?
- CytomX Therapeutics's net margin decreased by 1379.8% year-over-year, from 34% to -435.2%.
- What is the long-term trend for CytomX Therapeutics's net margin?
- Over 4 years (2020 to 2025), CytomX Therapeutics's net margin has grown at a -30.0% compound annual growth rate (CAGR), from -94.7% to -22.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about CytomX Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude